Pain relief for carpal tunnel syndrome using physiotherapy and medications
Pain Reduction Caused by the Combined Treatment of Neural Mobilization, Oral Gabapentin and Oral Ibuprofen Arginine in the Treatment of Carpal Tunnel Syndrome
This study is testing whether a mix of physiotherapy and medications can help people with carpal tunnel syndrome feel less pain and improve how their hands work.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Enrollment | 27 (estimated) |
| Ages | 18 Years to 70 Years |
| Sex | All |
| Sponsor | Universidad Europea de Madrid Academic / other |
| Locations | 1 site (Valencia, Carabobo) |
| Trial ID | NCT06781489 on ClinicalTrials.gov |
What this trial studies
This clinical trial investigates the effectiveness of a combined treatment approach for carpal tunnel syndrome, which includes physiotherapy techniques and medications. Participants will be randomly assigned to one of three groups: one receiving physiotherapy with gabapentin, another with ibuprofen arginine, and a control group receiving ibuprofen arginine alone. The study aims to compare pain reduction and functionality improvements in the affected upper limb among these groups. The trial will also assess the overall impact of these treatments on the symptoms of carpal tunnel syndrome.
Who should consider this trial
Good fit: Ideal candidates are individuals diagnosed with unilateral carpal tunnel syndrome who can understand Spanish and consent to participate.
Not a fit: Patients with cognitive impairments, recent surgeries, or those currently undergoing other pain treatments may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide a more effective pain management strategy for patients suffering from carpal tunnel syndrome.
How similar studies have performed: Previous studies have shown promising results with similar combined treatment approaches for pain management, suggesting potential for success in this trial.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Participants must be medically diagnosed with unilateral carpal tunnel syndrome (with confirmative electrodiagnostic findings). * Full understanding of written and spoken Spanish (language). * Participants must freely consent to participate. * The presence of positive Phalen an Tinel sings. * The presence of carpal tunnel syndrome signs and symptoms Exclusion Criteria: * The lack to meet inclusion criterions, the presence of cognitive impairment, tumors, cancer, recent (affected) upper limb surgery or trauma, pregnancy, kinesiophobia, deformities of the (affected) upper limb, recent skin injuries or infections (in the affected upper limb), autoimmune inflammatory conditions or flu type symptoms, allergy to gabapentin, allergy to ibuprofen arginine, and also: participants must not be (during the present investigation) under any type of pain reducing treatment (conservative, homeopathic, invasive or not invasive)
Where this trial is running
Valencia, Carabobo
- Ciudad Hospitalaria Enrique Tejera — Valencia, Carabobo, Venezuela (Recruiting)
Study contacts
- Principal investigator: Francisco Unda, PhD
- Study coordinator: Francisco Unda, PhD
- Email: 5299559@gmail.com
- Phone: 695634680
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.